A study to compare whether oral baclofen or oral tizanidine is better in patients presenting with tightness of the upper limb after stroke.

A study to compare efficacy of oral baclofen versus oral tizanidine in post stroke spasticity of upper limb. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/03/064651

Enrollment

Registered

2024-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G811- Spastic hemiplegia

Interventions

Intervention1: Oral baclofen: Oral anti-spastic drug used to reduce spasticity. Dose 30-50mg per day in divided doses for 6months orally Control Intervention1: Oral tizanidine: Oral anti-spastic drug

Eligibility

Inclusion criteria

Inclusion criteria: Non -diabetic

Exclusion criteria

Exclusion criteria: Diabetic

Design outcomes

Primary

Measure	Time frame
Modified Asthworth Scale for measurement of spasticity.Spasticity score of 2 and 3 were included.Timepoint: Visit 0(First visit) Visit 1(At 1 month) Visit 2(At 3 months) Visit 3(At 6 months)	—

Secondary

Measure	Time frame
Action Research Arm Test for measurement of upper limb function.Timepoint: Visit 0 (First visit) Visit 1 (At 1 month) Visit 2 (At 3 months) Visit 3 (At 6 months)	—

Countries

India

Contacts

Public ContactDrSudipan Mitra

Jalpaiguri Government Medical College and d Hospital

sudipanmitra_65@yahoo.com9836837658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026